NASDAQ:ALNY

Alnylam Pharmaceuticals SEC Filings & 10K Form

$138.88
-0.14 (-0.10 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$137.39
Now: $138.88
$140.06
50-Day Range
$133.80
MA: $141.24
$152.41
52-Week Range
$119.29
Now: $138.88
$178.41
Volume768,381 shs
Average Volume678,188 shs
Market Capitalization$16.29 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.47

SEC Filings

Alnylam Pharmaceuticals (NASDAQ:ALNY) SEC Filings

DateFilerForm TypeView
04/12/2021
4:00 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
3:48 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
04/02/2021
3:45 PM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
02/11/2021
3:36 PM
Alnylam Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/11/2021
3:13 PM
Alnylam Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2021
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2021
9:15 AM
Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/03/2021
12:33 PM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/01/2021
9:12 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
01/15/2021
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
10:57 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO LTD (Filed by)
Form SC 13G/A
01/13/2021
3:05 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
7:37 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
3:01 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:03 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
7:17 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
3:16 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
4:11 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:06 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:23 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
7:17 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:52 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:52 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:51 PM
Alnylam Pharmaceuticals (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:51 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:50 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:50 PM
Alnylam Pharmaceuticals (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:49 PM
Alnylam Pharmaceuticals (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:12 PM
Alnylam Pharmaceuticals (Filer)
Form S-3ASR
05/06/2020
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
3:07 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
3:06 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
3:22 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:51 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
7:56 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/04/2020
3:35 PM
Alnylam Pharmaceuticals (Issuer)
BRANDICOURT OLIVIER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
7:50 AM
Alnylam Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2020
7:29 AM
Alnylam Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
6:23 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
02/06/2020
7:28 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
8:15 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G
01/28/2020
11:05 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/13/2020
5:13 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:25 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
3:46 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2019
3:03 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
3:06 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:09 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:16 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:16 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:19 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
7:15 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:15 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
9:07 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
07/02/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:02 PM
Alnylam Pharmaceuticals (Subject)
Sanofi (Filed by)
Form SC 13G/A
05/02/2019
8:59 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
05/02/2019
8:58 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
05/01/2019
7:45 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:32 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
5:05 AM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
04/09/2019
3:43 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
3:24 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/21/2019
6:30 AM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
03/11/2019
4:07 PM
Alnylam Pharmaceuticals (Filer)
Form PRE 14A
03/01/2019
5:11 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:04 PM
Alnylam Pharmaceuticals (Subject)
DODGE & COX (Filed by)
Form SC 13G/A
02/11/2019
11:46 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.